Effect of Vitamin K2 Over Osteocalcin, Leptin, Cytokines, and Cardiovascular Risk in Young Adults With Overweight and Obesity
Overweight and Obesity, Cardiometabolic Risk Factors

About this trial
This is an interventional prevention trial for Overweight and Obesity focused on measuring Vitamin K, Overweight and Obesity, Cardiometabolic Risk Factors
Eligibility Criteria
Inclusion Criteria: Body Mass Index greater than 25 kg/m2 and less than 40 kg/m2 That they agree to participate in the study voluntarily and informed and sign the informed consent Exclusion Criteria: People with self-reported diagnosis of chronic kidney, gastrointestinal or systemic disease Use of bile acid sequestrants drugs, insulin, glucocorticoids, contraceptives, bisphosphonates, thiazides, levetiracetam, thiazolidinediones, anticoagulants or estrogenic drugs and vitamin D, vitamin K, vitamin A, vitamin E, omegas or calcium supplements Patients who are on a hypocaloric or low-fat diet Self-reported pregnancy
Sites / Locations
- University of Guadalajara
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Supplementation arm
Placebo arm
Vitamin K2
Cornstarch